NEA 14 GP, LTD's Net Worth
$167 Million
Who is NEA 14 GP, LTD?
NEA 14 GP, LTD has an estimated net worth of $167 Million. This is based on reported shares across multiple companies, which include Strongbridge Biopharma plc, INTERLEUKIN GENETICS INC, MULESOFT, INC, Oyster Point Pharma, Inc., APPIAN CORP, Mersana Therapeutics, Inc., Adaptimmune Therapeutics PLC, Loxo Oncology, Inc., CHAMPIONS ONCOLOGY, INC., Surface Oncology, Inc., Galera Therapeutics, Inc., Tracon Pharmaceuticals, Inc., SYNLOGIC, INC., Cerecor Inc., IMARA Inc., Casper Sleep Inc., and ZeroFox Holdings, Inc..
SEC CIK
NEA 14 GP, LTD's CIK is 0001551532
Past Insider Trading and Trends
2018 was NEA 14 GP, LTD's most active year for acquiring shares with 30 total transactions. NEA 14 GP, LTD's most active month to acquire stocks was the month of February. 2022 was NEA 14 GP, LTD's most active year for disposing of shares, totalling 19 transactions. NEA 14 GP, LTD's most active month to dispose stocks was the month of December. 2017 saw NEA 14 GP, LTD paying a total of $24,009,000.00 for 58,948,211 shares, this is the most they've acquired in one year. In 2017 NEA 14 GP, LTD cashed out on 70,082,988 shares for a total of $66,073,750.64, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Galera Therapeutics, Inc. (GRTX) Snapshot price: $0.1729
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.36M |
$12.00 |
—
| 4.36M |
Nov 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Oyster Point Pharma, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -5.93M |
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +1,737.54% | 5.6M |
$16.00 |
—
| 5.93M |
Nov 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Mersana Therapeutics, Inc. (MRSN) Snapshot price: $3.535
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -25.13% | -2.00M |
—
|
—
| 5.96M |
Sep 14
| |||
Form 4
| -33.45% | -4.00M |
—
|
—
| 7.96M |
Apr 9
| |||
Form 4
| +0.58% | 69.38K |
$1.48 | $5.64 | 11.96M |
Aug 28
| |||
Form 4
| +46.07% | 3.75M |
$4.00 | $15,000,000.00 | 11.89M |
Mar 5
| |||
Form 4
|
∞
| 8.14M |
$15.00 |
—
| 8.14M |
Jul 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Tracon Pharmaceuticals, Inc. (TCON) Snapshot price: $0.1909
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +25.67% | 707.96K |
$2.70 | $1,911,502.80 | 3.47M |
Mar 27
| |||
Form 4
| +25.67% | 707.96K |
$2.70 | $1,911,502.80 | 3.47M |
Mar 27
| |||
Form 4
| +25.67% | 707.96K |
$2.70 | $1,911,502.80 | 3.47M |
Mar 27
| |||
Form 4
| +25.67% | 707.96K |
$2.70 | $1,911,502.80 | 3.47M |
Mar 27
| |||
Form 4
| +25.67% | 707.96K |
$2.70 | $1,911,502.80 | 3.47M |
Mar 27
| |||
Form 4
| +25.67% | 707.96K |
$2.70 | $1,911,502.80 | 3.47M |
Mar 27
| |||
Form 4
| +25.67% | 707.96K |
$2.70 | $1,911,502.80 | 3.47M |
Mar 27
| |||
Form 4
| +25.67% | 707.96K |
$2.70 | $1,911,502.80 | 3.47M |
Mar 27
| |||
Form 4
| +25.67% | 707.96K |
$2.70 | $1,911,502.80 | 3.47M |
Mar 27
| |||
Form 4
| +25.67% | 707.96K |
$2.70 | $1,911,502.80 | 3.47M |
Mar 27
| |||
Form 4
| +46.05% | 869.57K |
$5.75 | $4,999,998.75 | 2.76M |
Nov 29
| |||
Form 4
|
∞
| 1.89M |
$10.00 |
—
| 1.89M |
Feb 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Casper Sleep Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.22M |
$6.90 | -$42,935,263.80 |
0
|
Jan 25
| |||
Form 4
| +25.14% | 1.25M |
$12.00 | $15,000,000.00 | 6.22M |
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |